Global Generic Injection Market Research Report 2024

Publication ID:

PB505258592

Publication Date:

May 14, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.
The global Generic Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Generic Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injection.
Report Scope
The Generic Injection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Generic Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Injection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group
Segment by Type
Liquid Injection
Powder for Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Injection companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Injection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liquid Injection
1.2.3 Powder for Injection
1.3 Market by Application
1.3.1 Global Generic Injection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Injection Market Perspective (2019-2030)
2.2 Generic Injection Growth Trends by Region
2.2.1 Global Generic Injection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Generic Injection Historic Market Size by Region (2019-2024)
2.2.3 Generic Injection Forecasted Market Size by Region (2025-2030)
2.3 Generic Injection Market Dynamics
2.3.1 Generic Injection Industry Trends
2.3.2 Generic Injection Market Drivers
2.3.3 Generic Injection Market Challenges
2.3.4 Generic Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Injection Players by Revenue
3.1.1 Global Top Generic Injection Players by Revenue (2019-2024)
3.1.2 Global Generic Injection Revenue Market Share by Players (2019-2024)
3.2 Global Generic Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Injection Revenue
3.4 Global Generic Injection Market Concentration Ratio
3.4.1 Global Generic Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Injection Revenue in 2023
3.5 Generic Injection Key Players Head office and Area Served
3.6 Key Players Generic Injection Product Solution and Service
3.7 Date of Enter into Generic Injection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Injection Breakdown Data by Type
4.1 Global Generic Injection Historic Market Size by Type (2019-2024)
4.2 Global Generic Injection Forecasted Market Size by Type (2025-2030)
5 Generic Injection Breakdown Data by Application
5.1 Global Generic Injection Historic Market Size by Application (2019-2024)
5.2 Global Generic Injection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Generic Injection Market Size (2019-2030)
6.2 North America Generic Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Generic Injection Market Size by Country (2019-2024)
6.4 North America Generic Injection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Injection Market Size (2019-2030)
7.2 Europe Generic Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Generic Injection Market Size by Country (2019-2024)
7.4 Europe Generic Injection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Injection Market Size (2019-2030)
8.2 Asia-Pacific Generic Injection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Generic Injection Market Size by Region (2019-2024)
8.4 Asia-Pacific Generic Injection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Injection Market Size (2019-2030)
9.2 Latin America Generic Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Generic Injection Market Size by Country (2019-2024)
9.4 Latin America Generic Injection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Injection Market Size (2019-2030)
10.2 Middle East & Africa Generic Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Generic Injection Market Size by Country (2019-2024)
10.4 Middle East & Africa Generic Injection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Generic Injection Introduction
11.1.4 Sanofi Revenue in Generic Injection Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Fresenius
11.2.1 Fresenius Company Detail
11.2.2 Fresenius Business Overview
11.2.3 Fresenius Generic Injection Introduction
11.2.4 Fresenius Revenue in Generic Injection Business (2019-2024)
11.2.5 Fresenius Recent Development
11.3 Viatris
11.3.1 Viatris Company Detail
11.3.2 Viatris Business Overview
11.3.3 Viatris Generic Injection Introduction
11.3.4 Viatris Revenue in Generic Injection Business (2019-2024)
11.3.5 Viatris Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Generic Injection Introduction
11.4.4 Pfizer Revenue in Generic Injection Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Generic Injection Introduction
11.5.4 Teva Pharmaceuticals Revenue in Generic Injection Business (2019-2024)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Hikma Pharmaceuticals
11.6.1 Hikma Pharmaceuticals Company Detail
11.6.2 Hikma Pharmaceuticals Business Overview
11.6.3 Hikma Pharmaceuticals Generic Injection Introduction
11.6.4 Hikma Pharmaceuticals Revenue in Generic Injection Business (2019-2024)
11.6.5 Hikma Pharmaceuticals Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Generic Injection Introduction
11.7.4 Novartis Revenue in Generic Injection Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Detail
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Generic Injection Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Generic Injection Business (2019-2024)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Gland Pharma
11.9.1 Gland Pharma Company Detail
11.9.2 Gland Pharma Business Overview
11.9.3 Gland Pharma Generic Injection Introduction
11.9.4 Gland Pharma Revenue in Generic Injection Business (2019-2024)
11.9.5 Gland Pharma Recent Development
11.10 Allergan
11.10.1 Allergan Company Detail
11.10.2 Allergan Business Overview
11.10.3 Allergan Generic Injection Introduction
11.10.4 Allergan Revenue in Generic Injection Business (2019-2024)
11.10.5 Allergan Recent Development
11.11 Kelun Pharmaceutical
11.11.1 Kelun Pharmaceutical Company Detail
11.11.2 Kelun Pharmaceutical Business Overview
11.11.3 Kelun Pharmaceutical Generic Injection Introduction
11.11.4 Kelun Pharmaceutical Revenue in Generic Injection Business (2019-2024)
11.11.5 Kelun Pharmaceutical Recent Development
11.12 Jiangsu HRS
11.12.1 Jiangsu HRS Company Detail
11.12.2 Jiangsu HRS Business Overview
11.12.3 Jiangsu HRS Generic Injection Introduction
11.12.4 Jiangsu HRS Revenue in Generic Injection Business (2019-2024)
11.12.5 Jiangsu HRS Recent Development
11.13 Qilu Pharmaceutical
11.13.1 Qilu Pharmaceutical Company Detail
11.13.2 Qilu Pharmaceutical Business Overview
11.13.3 Qilu Pharmaceutical Generic Injection Introduction
11.13.4 Qilu Pharmaceutical Revenue in Generic Injection Business (2019-2024)
11.13.5 Qilu Pharmaceutical Recent Development
11.14 Chiatai Tianqing
11.14.1 Chiatai Tianqing Company Detail
11.14.2 Chiatai Tianqing Business Overview
11.14.3 Chiatai Tianqing Generic Injection Introduction
11.14.4 Chiatai Tianqing Revenue in Generic Injection Business (2019-2024)
11.14.5 Chiatai Tianqing Recent Development
11.15 Hainan Poly Pharm
11.15.1 Hainan Poly Pharm Company Detail
11.15.2 Hainan Poly Pharm Business Overview
11.15.3 Hainan Poly Pharm Generic Injection Introduction
11.15.4 Hainan Poly Pharm Revenue in Generic Injection Business (2019-2024)
11.15.5 Hainan Poly Pharm Recent Development
11.16 Yangzijiang Pharmaceutical Industry
11.16.1 Yangzijiang Pharmaceutical Industry Company Detail
11.16.2 Yangzijiang Pharmaceutical Industry Business Overview
11.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Introduction
11.16.4 Yangzijiang Pharmaceutical Industry Revenue in Generic Injection Business (2019-2024)
11.16.5 Yangzijiang Pharmaceutical Industry Recent Development
11.17 Shijiazhuang Pharma Group
11.17.1 Shijiazhuang Pharma Group Company Detail
11.17.2 Shijiazhuang Pharma Group Business Overview
11.17.3 Shijiazhuang Pharma Group Generic Injection Introduction
11.17.4 Shijiazhuang Pharma Group Revenue in Generic Injection Business (2019-2024)
11.17.5 Shijiazhuang Pharma Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂